K
Karin Zedeler
Researcher at University of Copenhagen
Publications - 17
Citations - 3459
Karin Zedeler is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Breast cancer & Mastectomy. The author has an hindex of 14, co-authored 17 publications receiving 3348 citations.
Papers
More filters
Journal ArticleDOI
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
Marie Overgaard,Per S. Hansen,Jens Overgaard,Carsten Rose,Martin Andersson,Flemming W. Bach,Mogens Kjaer,Carl C. Gadeberg,Henning T. Mouridsen,Maj-Britt Jensen,Karin Zedeler +10 more
TL;DR: Multivariate analysis demonstrated that irradiation after mastectomy significantly improved disease-free survival and overall survival, irrespective of tumor size, the number of positive nodes, or the histopathological grade.
Journal ArticleDOI
Axillary dissection of level I and II lymph nodes is important in breast cancer classification
TL;DR: In this article, the axillary nodal status at the primary operation for breast cancer was evaluated in 13,851 patients registered by the Danish Breast Cancer Cooperative Group (DBCG).
Journal ArticleDOI
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)
Ingegerd Balslev,Christen Kirk Axelsson,Karin Zedeler,Birgitte Bruun Rasmussen,Bendix Carstensen,Henning T. Mouridsen +5 more
TL;DR: The Nottingham Prognostic Index defined a subset of patients having so good prognosis that adjuvant therapy can be withhold, but it did not succeed in defining a subset with survival similar to the expected; additional prognostic factors are therefore needed.
Journal ArticleDOI
Patient's and Doctor's Delay in Primary Breast Cancer: Prognostic implications
TL;DR: The study suggests that all sources of delays should be kept at a minimum and indicates that doctors are capable of distinguishing between more and less aggressive malignancies.
Journal ArticleDOI
Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial
Marie Overgaard,J. Juul Christensen,Helle Krogh Johansen,A. Nybo-Rasmussen,Carsten Rose,P. van der Kooy,J Panduro,F. Laursen,Mogens Kjaer,N.E. Sørensen,Carl C. Gadeberg,M. Hjelm-Hansen,Jens Overgaard,K. West Andersen,Karin Zedeler +14 more
TL;DR: Overall survival is significantly different in 82-b patients but not in post-menopausal 82-c patients, and adjuvant systemic treatment alone (chemotherapy or tamoxifen) did not prevent loco-regional recurrences in high-risk patients after mastectomy and axillary lymph node sampling.